NEUROCRINE BIOSCIENCES INC (NBIX)
Sector: Health Care
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Sector: Health Care
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Director information for NBIX
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
| NBIX | ["Financial Expertise / Capital Management and Allocation","Commercial Strategy/Market Access","Drug Development","Healthcare Industry","Biotech and Pharma Operations Expertise","M&A/Business Development Transactions","Governance","Investor Relations","Executive Leadership","Risk Management Oversight","Human Capital Management"] | ["Audit","Compensation","Nominating /Corporate Governance","Science and Medical Technology"] | 2026 |
Biography sourced from the proxy statement filing.
Gary A. Lyons has served on the Board of Directors since joining Neurocrine Biosciences in February 1993. Mr. Lyons served as the President and CEO of the Company from February 1993 through January 2008. Prior to joining the Company, Mr. Lyons held a number of senior management posit